We are live on ! Find out more
ACM

Athyrium Capital Management Portfolio holdings

AUM $8.69M
1-Year Est. Return 34.58%
This Fund
S&P 500
This Quarter Est. Return
-27.6%
1 Year Est. Return
-34.58%
3 Year Est. Return
-25.1%
5 Year Est. Return
10 Year Est. Return
AUM
$158M
AUM Growth
-$82.2M
Cap. Flow
+$5.99M
Cap. Flow %
3.8%
Top 10 Hldgs %
100%
Holding
4
New
Increased
1
Reduced
Closed

Top Buys

Rank Stock Value
1
CMAX
CareMax, Inc. Class A Common Stock
CMAX
+$5.99M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BIOR
1
DELISTED
Biora Therapeutics, Inc. Common Stock
BIOR
$55.3M 35.09%
145,588
AMYT
2
DELISTED
Amryt Pharma plc American Depositary Shares
AMYT
$54.4M 34.53%
4,520,000
CMAX
3
DELISTED
CareMax, Inc. Class A Common Stock
CMAX
$43.3M 27.5%
149,574
+20,355
+16% +$5.99M
SCTL
4
DELISTED
Societal CDMO, Inc. Common Stock
SCTL
$4.54M 2.88%
2,202,420

Similar funds

Athyrium Capital Management's Q3 2021 Portfolio in Review

As of Q3 2021, Athyrium Capital Management held 4 positions worth $158M, down 34% from $240M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Athyrium Capital Management deployed $5.99M of net new capital in Q3 2021, adding to 1 existing holding.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • Athyrium Capital Management added most to CareMax, Inc. Class A Common Stock in Q3 2021, an estimated $5.99M increase.
  • Athyrium Capital Management's ten largest holdings make up 100% of its $158M portfolio in Q3 2021.
  • Athyrium Capital Management opened 0 new positions and closed 0 in Q3 2021.
  • Athyrium Capital Management's portfolio value fell 34% quarter-over-quarter to $158M.

Based on Athyrium Capital Management's 13F filing for Q3 2021, filed 15 Nov 2021.